文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

SEanalysis 2.0:一个用于人类和小鼠的全面超级增强子调控网络分析工具。

SEanalysis 2.0: a comprehensive super-enhancer regulatory network analysis tool for human and mouse.

机构信息

The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.

The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.

出版信息

Nucleic Acids Res. 2023 Jul 5;51(W1):W520-W527. doi: 10.1093/nar/gkad408.


DOI:10.1093/nar/gkad408
PMID:37194711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10320134/
Abstract

Super-enhancers (SEs) play an essential regulatory role in various biological processes and diseases through their specific interaction with transcription factors (TFs). Here, we present the release of SEanalysis 2.0 (http://licpathway.net/SEanalysis), an updated version of the SEanalysis web server for the comprehensive analyses of transcriptional regulatory networks formed by SEs, pathways, TFs, and genes. The current version added mouse SEs and further expanded the scale of human SEs, documenting 1 167 518 human SEs from 1739 samples and 550 226 mouse SEs from 931 samples. The SE-related samples in SEanalysis 2.0 were more than five times that in version 1.0, which significantly improved the ability of original SE-related network analyses ('pathway downstream analysis', 'upstream regulatory analysis' and 'genomic region annotation') for understanding context-specific gene regulation. Furthermore, we designed two novel analysis models, 'TF regulatory analysis' and 'Sample comparative analysis' for supporting more comprehensive analyses of SE regulatory networks driven by TFs. Further, the risk SNPs were annotated to the SE regions to provide potential SE-related disease/trait information. Hence, we believe that SEanalysis 2.0 has significantly expanded the data and analytical capabilities of SEs, which helps researchers in an in-depth understanding of the regulatory mechanisms of SEs.

摘要

超级增强子(SEs)通过与转录因子(TFs)的特定相互作用,在各种生物过程和疾病中发挥着重要的调节作用。在这里,我们发布了 SEanalysis 2.0(http://licpathway.net/SEanalysis),这是 SEanalysis 网络服务器的更新版本,用于全面分析由 SEs、途径、TFs 和基因形成的转录调控网络。当前版本增加了小鼠 SEs,并进一步扩大了人类 SEs 的规模,记录了来自 1739 个样本的 1167518 个人类 SEs 和来自 931 个样本的 550226 个小鼠 SEs。SEanalysis 2.0 中的 SE 相关样本是版本 1.0 的五倍多,这显著提高了原始 SE 相关网络分析(“下游途径分析”、“上游调控分析”和“基因组区域注释”)的能力,有助于理解特定于上下文的基因调控。此外,我们设计了两个新的分析模型,“TF 调控分析”和“样本比较分析”,用于支持更全面的 TF 驱动的 SE 调控网络分析。此外,将风险 SNPs 注释到 SE 区域,以提供潜在的 SE 相关疾病/特征信息。因此,我们相信 SEanalysis 2.0 极大地扩展了 SE 的数据和分析能力,有助于研究人员深入了解 SE 的调控机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecfe/10320134/2a9be82ba740/gkad408fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecfe/10320134/81b5aa9eaf86/gkad408figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecfe/10320134/9be994a32ab7/gkad408fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecfe/10320134/2a9be82ba740/gkad408fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecfe/10320134/81b5aa9eaf86/gkad408figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecfe/10320134/9be994a32ab7/gkad408fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecfe/10320134/2a9be82ba740/gkad408fig2.jpg

相似文献

[1]
SEanalysis 2.0: a comprehensive super-enhancer regulatory network analysis tool for human and mouse.

Nucleic Acids Res. 2023-7-5

[2]
SEanalysis: a web tool for super-enhancer associated regulatory analysis.

Nucleic Acids Res. 2019-7-2

[3]
SEdb 2.0: a comprehensive super-enhancer database of human and mouse.

Nucleic Acids Res. 2023-1-6

[4]
SEdb: a comprehensive human super-enhancer database.

Nucleic Acids Res. 2019-1-8

[5]
The super-enhancer repertoire in porcine liver.

J Anim Sci. 2023-1-3

[6]
Landscape and significance of human super enhancer-driven core transcription regulatory circuitry.

Mol Ther Nucleic Acids. 2023-3-24

[7]
TcoFBase: a comprehensive database for decoding the regulatory transcription co-factors in human and mouse.

Nucleic Acids Res. 2022-1-7

[8]
SEA version 3.0: a comprehensive extension and update of the Super-Enhancer archive.

Nucleic Acids Res. 2020-1-8

[9]
Super-enhancer-guided mapping of regulatory networks controlling mouse trophoblast stem cells.

Nat Commun. 2019-10-18

[10]
TRmir: A Comprehensive Resource for Human Transcriptional Regulatory Information of MiRNAs.

Front Genet. 2022-2-4

引用本文的文献

[1]
CRISPR/Cas9 in colorectal cancer: Revolutionizing precision oncology through genome editing and targeted therapeutics.

Iran J Basic Med Sci. 2025

[2]
When the victim becomes the villain: Platelets as drivers of immune dysregulation in ITP.

J Transl Autoimmun. 2025-8-19

[3]
Stable Dopamine-Signaling mRNA Co-Expression in the Substantia Nigra Is Deregulated in Pathological Conditions, but Not in Dopamine Transporter Knockout Rats.

Biomolecules. 2025-8-3

[4]
Mechanistic Insights Into the Tumor-Driving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In Vitro Analysis.

Cancer Med. 2025-8

[5]
Multi-Omics analysis and in vitro validation reveal diagnostic and therapeutic roles of novel hub genes in ovarian cancer.

Hereditas. 2025-8-18

[6]
A comprehensive in silico and invitro analysis revealed the diagnostic, prognostic and therapeutic potential of GNAI family genes in colon adenocarcinoma (COAD).

Hereditas. 2025-8-16

[7]
Multi-omics approach reveals CCND1, GABPA, HIF1A, and SOX6 as key regulators and prognostic markers in heart failure.

Hereditas. 2025-8-16

[8]
In silico and in vitro assessment of TP53, ATM, RAD51, and BAX genes in gastric cancer and their contribution to radiotherapy resistance.

Hereditas. 2025-7-12

[9]
Functions and mechanisms of long non-coding RNA in esophageal squamous cell carcinoma (Review).

Oncol Lett. 2025-7-1

[10]
CanASM: a comprehensive database for genome-wide allele-specific DNA methylation identification and annotation in cancer.

BMC Genomics. 2025-7-9

本文引用的文献

[1]
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.

Mol Cancer. 2023-1-18

[2]
Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2023.

Nucleic Acids Res. 2023-1-6

[3]
PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression.

Nat Commun. 2022-5-19

[4]
ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data.

Nucleic Acids Res. 2022-7-5

[5]
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER breast cancer.

Nat Commun. 2022-2-25

[6]
STAT3-mediated allelic imbalance of novel genetic variant Rs1047643 and B-cell-specific super-enhancer in association with systemic lupus erythematosus.

Elife. 2022-2-21

[7]
Multimodal regulatory elements within a hormone-specific super enhancer control a heterogeneous transcriptional response.

Mol Cell. 2022-2-17

[8]
TF-Marker: a comprehensive manually curated database for transcription factors and related markers in specific cell and tissue types in human.

Nucleic Acids Res. 2022-1-7

[9]
ReMap 2022: a database of Human, Mouse, Drosophila and Arabidopsis regulatory regions from an integrative analysis of DNA-binding sequencing experiments.

Nucleic Acids Res. 2022-1-7

[10]
The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes.

Clin Epigenetics. 2021-7-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索